Advertisement

Advertisement

AYTU Stock Latest News

Aytu BioScience Bets on EXXUA Amid Legacy Declines

Company AnnouncementsAytu BioScience Bets on EXXUA Amid Legacy Declines

Aytu BioScience Earnings Call: EXXUA Drives Transition

PremiumCompany Announcements

Aytu BioScience Earnings Call: EXXUA Drives Transition

17d ago

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

PremiumThe Fly

Aytu BioPharma reports Q3 EPS (53c), consensus (43c)

18d ago

AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

AYTU Earnings Report this Week: Is It a Buy, Ahead of Earnings?

21d ago

Aytu BioScience Amends Warrants, Modifying Security Holder Rights

PremiumCompany Announcements

Aytu BioScience Amends Warrants, Modifying Security Holder Rights

2M ago

Aytu BioScience Earnings Call: ExuA Launch vs. Headwinds

PremiumCompany AnnouncementsAytu BioScience Earnings Call: ExuA Launch vs. Headwinds

4M ago

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

The Fly

Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year

4M ago

Is AYTU a Buy, Before Earnings?

Pre-Earnings

Is AYTU a Buy, Before Earnings?

4M ago

Aytu BioPharma Highlights EXXUA Opportunity at Investor Day

PremiumCompany Announcements

Aytu BioPharma Highlights EXXUA Opportunity at Investor Day

4M ago

Aytu BioPharma announces nationwide commercial launch of EXXUA

PremiumThe Fly

Aytu BioPharma announces nationwide commercial launch of EXXUA

4M ago

Aytu BioPharma announces commercial availability of EXXUA tablets

PremiumThe Fly

Aytu BioPharma announces commercial availability of EXXUA tablets

6M ago

Aytu BioScience Stockholders Approve Key Proposals

PremiumCompany Announcements

Aytu BioScience Stockholders Approve Key Proposals

6M ago

Aytu BioScience Earnings Call Highlights Growth and Challenges

PremiumCompany AnnouncementsAytu BioScience Earnings Call Highlights Growth and Challenges

7M ago

Aytu BioScience: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Ratings

Aytu BioScience: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

7M ago

Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans

Company Announcements

Aytu BioPharma Reports Q1 2026 Earnings and EXXUA Launch Plans

7M ago

Aytu BioScience (AYTU) Q1 Earnings Cheat Sheet

PremiumPre-Earnings

Aytu BioScience (AYTU) Q1 Earnings Cheat Sheet

7M ago

Aytu BioPharma announces patent term extension for EXXUA

PremiumThe Fly

Aytu BioPharma announces patent term extension for EXXUA

7M ago

Aytu BioPharma management to meet with Lake Street

PremiumThe Fly

Aytu BioPharma management to meet with Lake Street

8M ago

Aytu BioPharma price target lowered to $7 from $9 at Maxim

PremiumThe Fly

Aytu BioPharma price target lowered to $7 from $9 at Maxim

8M ago

Aytu BioPharma’s Optimistic Earnings Call Highlights ExuA Launch

PremiumCompany AnnouncementsAytu BioPharma’s Optimistic Earnings Call Highlights ExuA Launch

8M ago

Aytu BioPharma price target lowered to $7 from $9 at Maxim

The Fly

Aytu BioPharma price target lowered to $7 from $9 at Maxim

8M ago

Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans

Company Announcements

Aytu BioPharma Reports Fiscal 2025 Earnings and EXXUA Launch Plans

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >